LMWH Use for VTE Prophylaxis in COVID-19 Hospitalized Patients – Multicenter Data from China
Thrombosis Journal posted on X:
”Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China.”
A multicenter prospective study in China (Dec 2022–Jan 2023) analyzed real-world use of low-molecular-weight heparin (LMWH) in 4,236 hospitalized COVID-19 patients.
Thromboprophylaxis practices varied widely, with many receiving reduced doses; dosing and duration were influenced by age, disease severity, renal function, platelet count, anemia, and concurrent antiviral or corticosteroid use.
Read the full article here.
Article: Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China
Authors: Feiya Xu, Yuzhi Tao, Lijun Chen, Yunhui Zhang, Binliang Wang, Jing Han, Chaosheng Deng, Weijia Liu, Guohui Fan, Rui Liang, Zhaofei Chen, Yinong Chen, Kaiyuan Zhen, Yunxia Zhang, Zhu Zhang, Shuai Zhang, Jun Wan, Wanmu Xie, Peiran Yang, YuTing Kang, Dingyi Wang, Chen Wang, Zhenguo Zhai
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Sep 7, 2026, 09:31Felix Scholkmann: Serotonin and the Formation of Microvascular Fibrin
-
Sep 7, 2026, 09:22Aryan Mishra: β-Thalassemia Analyzer: HPLC for Hemoglobinopathy Screening
-
Sep 7, 2026, 09:04Daniel Pereira Monteiro: Haemopaedia Case of the Week – Hemoglobinopathy Diagnosis and Confirmatory Testing
-
Sep 7, 2026, 08:51Judith de Vos: The Immune Composition of Thrombi in Ischemic Stroke
-
Sep 7, 2026, 08:50Maria Cherska: Lipid Metabolism and Immune Remodeling in Metastatic Colorectal Cancer
-
Sep 7, 2026, 08:28Deanna Joseph: Exploring Factor XIII Deficiency Through Summer Research
-
Sep 7, 2026, 08:17Nasim Hosseini: Women’s Blood Donation and the Social Determinants of Health
-
Sep 7, 2026, 08:12David McIntosh: The Global Plasma Supply Debate
-
Sep 7, 2026, 08:03Julio Avella: Advancing IDA Care Through Scientific Education and Collaboration